Consensus

Thanks, Jason Braun, M.Ed., MA, CSM, for your insightful article on how AI tools have positively impacted your life and for sharing an example of how you use Consensus! See the full story: https://lnkd.in/gTMe_gG3 "In fact, I use voice computing via Consensus on the GPT app almost every day as I'm walking my dog. For me, it's a kind of note-taking habit. I'll be listening to an audiobook or podcast and then go to the app and dictate a prompt exactly like this: Acting with expertise similar to a senior faculty member at MIT's Media Lab, please locate ten recent, well-cited research articles discussing why individuals with ADHD and dyslexia might excel in user experience or interface design. These articles should explore how neurodivergent individuals may uniquely perceive patterns and experience confusion more intensely than typical users. Present the findings as an APA-style annotated bibliography with a pulled quote from each. This approach allows me to capture complex ideas and research queries effortlessly, leveraging AI to enhance my academic work and thought processes. It's a prime example of how AI-powered assistive technologies can transform daily routines into productive, intellectual exercises for neurodivergent individuals."

🔬 Check out July's science digest! The most interesting science news from around the world. This month, we summarise recent research on anti-obesity drugs, discover an underground cave on the moon, learn about the last universal common ancestor, and more. Check out the full article on the Consensus website under 'Science content' - Consensus Science Digest #3. Written by our science content partner - DR. EVA HAMRUD: I am a bioinformatician with a primary research interest in stem cell biology. I am also passionate about all areas of scientific research and their communication. MEDICINE New research sheds light on how anti-obesity drugs work GLP-1 drugs mimic the naturally occurring hormone, glucagon peptide-1 (GLP-1), which is released when we eat food. These drugs have been used to control type 2 diabetes for several years, and more recently some GLP-1 drugs have obtained FDA approval for obesity. Some of the most successful GLP-1 drugs such as Ozempic and Wegovy have attained high profiles, and in 2023 the drug company Novo Nordisk made over 21 billion US dollars from GLP-1 drugs. Due to their widespread usage, more data is now available for scientists to better understand how these medications work and what unintended effects they may have on the body.   How do GLP-1 drugs work? GLP-1 was originally used for diabetes as it triggers the release of insulin, which in turn tells the body to absorb glucose from the bloodstream. Its weight-loss ability, however, appears to be due to an effect on the brain. One of the ways that these anti-obesity drugs promote weight loss is by making people feel full, even if they haven’t eaten. Last month, scientists have identified that this feeling of fullness is controlled by a group of neurons which are different from the neurons that make you feel full after a big meal. Stimulating these neurons in feeding mice caused them to stop eating immediately. This exciting discovery may provide the groundwork for more drugs to be developed to increase feelings of fullness before eating whilst avoiding other effects on insulin. Do GLP-1 drugs have side effects? GLP-1 drugs come with a range of side effects including vomiting, diarrhoea and constipation. One of the most common side effects is nausea, and in some cases this effect prevents people from continuing usage. This month, researchers from the University of Pennsylvania in the USA found that the neural circuits in the back of the brain that cause nausea, are independent from those that cause feelings of fullness. This finding provides an exciting opportunity to develop new anti-obesity drugs which selectively target the neurons that make you feel full, but don’t make you feel sick. Read the full article on our website!

🔬 Welcome to our new science digest! Interesting science news from around the world. This month, we learn about the creation of a robotic thumb, celebrate a major breakthrough in IBD research, and consider the potential uses of graphene, the next ‘wonder material’. Check out the stories we cover this month! Written by our science content partner - DR. EVA HAMRUD: I am a bioinformatician with a primary research interest in stem cell biology. I am also passionate about all areas of scientific research and their communication. https://lnkd.in/gQCXA8fz

🖱️Select your language for our AI features! ✨ We're pleased to introduce over 30 language options: Select your language of choice to translate text in Copilot, Summaries, and Paper Takeaways (all on our search results page). • Simply go to your account page https://lnkd.in/gGhsEWdR • Select your language • Then search in your language and see the results translated If your desired language is missing from the list, just let us know so we can add it! Try Consensus for free and get evidence-based insights. 🤓

😎 We've got a new look. The same Consensus you know and love, just a little fresher, more modern, and bright. ❤️ Check out our sleeker product UX with a query today, or take a scroll through some of our new website pages and science content.

Pablo Garcés only joined Consensus 2 months ago as our Founding Designer and he's already helped ship a full re-design of our product and brand. Can't wait to see all of the amazing work to come 🏗

I’m excited to share my first project since joining Consensus - our brand product refresh! After nearly 4 great years at Quora and Poe, I’ve joined Consensus as the Founding Product Designer to work on making the world’s best knowledge - currently trapped in dense academic papers - more accessible to all. We’ve started towards this mission by developing an AI-powered search engine that prioritizes high-quality, semantically relevant studies for every query and always cites its sources. Despite being a small team of 10, our product has already helped millions of students, researchers, doctors, and more access and collate this type of knowledge more easily. This brand product refresh marks the next step on our mission to open up this type of knowledge to more and more people. Stay tuned - there’s much more to come! Special thanks to everyone on the team for getting this out; check it out at https://consensus.app!

Christian Salem, our Co-Founder and CPO, recently sat down with Cerebral Valley to discuss the journey of Consensus and our mission to revolutionize academic research! In this in-depth interview, Christian highlights: 🔍 The inspiration behind Consensus and our unique "Google Scholar meets GPT" approach. 🤖 How we're leveraging over 25 different LLMs to automate and enhance the research workflow. 🎓 Our diverse user base, from students to physicians, all are finding immense value in our platform. 🔧 The technical challenges we've overcome, particularly in building a robust and precise search engine. 🔮 Our future roadmap focuses on improving search relevance, adding more AI-driven features, and supporting team collaborations. Read the full linked interview below...

Consensus now uses GPT-4o ✨ This makes our Copilot and other AI-powered features faster, smarter, and more capable in 50 languages 🤖 Just enter your query in your language of choice and see how Copilot can easily translate the response: https://lnkd.in/exGC4u58 More shipping next week! If you'd like us to build something specific with the new GPT-4o capabilities, please let us know 🙏

❤️ 💜